Drug Profile
Research programme: Parkinson's disease therapeutics - Integrative Research Laboratories
Alternative Names: IRL 448; IRL 555Latest Information Update: 28 Feb 2023
Price :
$50
*
At a glance
- Originator Integrative Research Laboratories
- Class Antidementias; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 28 Feb 2023 No recent reports of development identified for preclinical development in Parkinson's-disease in Sweden
- 23 Feb 2021 Preclinical development is ongoing in Sweden Integrative Research Laboratories, February 2021
- 28 Apr 2020 No recent reports of development identified for preclinical development in Parkinson's-disease in Sweden